Arrowhead Pharma (ARWR) PT Raised to $123 at B.Riley
Tweet
Share
E-mailGet Alerts ARWR Hot Sheet
Price: $66.48 -1.86%
Rating Summary:
18 Buy, 5 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 9 | New: 26
Rating Summary:
18 Buy, 5 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 9 | New: 26
Join SI Premium – FREE
B.Riley analyst Chad L. Mabry raised the price target on Arrowhead Pharma (NASDAQ: ARWR) to $123.00 (from $101.00) while maintaining a Buy rating.
You May Also Be Interested In
- Securitize Corp (SECZ) PT Raised to $12 at StoneX on 'Innovation Exemption'
- Arrowhead reports early data for dual-gene RNAi therapy ARO-DIMER-PA
- CAVA Group Inc (CAVA) PT Lowered to $80 at JPMorgan, Overweight Rating Maintained
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
